|
An exploratory double-blind, placebo-controlled, randomized, 12-week, oral dose study to evaluate the effects of MD-0736 on atherosclerotic disease biomarkers in lower extremity plaque excised from patients with peripheral arterial disease.
Principal Investigator: Tony Das, M.D.
|
